Products & deployments

  • Artificial biosensor measures stress hormone at home

    A new biosensor can detect cortisol — the body’s main stress hormone — using a smartphone camera and a small blood or urine sample. The sensor uses designed proteins that bind with cortisol — a hormone that helps regulate blood pressure, metabolism and stress responses — and emit light. The amount of light corresponds to [...]

  • Council transforms employee expertise into AI chatbot

    A UK council has turned one employee’s 35 years of experience into an AI chatbot to support colleagues working in adult social care. Geraldine Jinks, a therapy practitioner at Peterborough City Council, was often asked for advice on care-related queries. After her manager recognised how much time this was taking, the council developed Hey Geraldine [...]

  • Dr Julian launches affordable ADHD Pre-Screen Consultations

    Dr Julian, the UK’s highest-rated digital mental health platform, has launched a cost effective, digital ADHD Pre-Screen Consultation service to help employers, occupational health teams and NHS partners fast-track access into specialist services for individuals showing signs of ADHD. The new service offers affordable, specialist-led consultations within days, significantly reducing the wait associated with traditional [...]

  • AI-powered brain stimulation at home could enhance focus, study finds

    A new AI-powered brain stimulation system could improve focus during challenging tasks, allowing people to enhance concentration from home. The personalised system combines transcranial random noise stimulation (tRNS) – a gentle and painless form of electrical brain stimulation – with artificial intelligence that adjusts settings based on individual traits, such as attention levels and head [...]

  • Nerve-zapping stimulator ‘could help improve fitness,’ study finds

    An ear-worn device that stimulates a major nerve has been shown to improve exercise performance in an early-stage trial involving healthy volunteers. The device sends gentle electrical pulses to the vagus nerve – which runs from the brain to the heart and helps regulate heart function – for 30 minutes a day. Participants who wore [...]

  • Game will help young people navigate adversity

    A serious video game developed in Cornwall aims to help young people explore mental health challenges linked to adverse childhood experiences such as bereavement or poverty. The Ace of Hearts game is part of ATTUNE, a £35m UK-wide programme using arts-based methods, including gaming, to explore how negative early experiences affect mental health. Developers at [...]

  • Aidoc raises US$150m for clinical AI expansion

    Aidoc has raised US$150m to expand CARE, its clinical AI platform that helps doctors make faster, more accurate medical decisions at the point of care. The funding round was led by General Catalyst and Square Peg, with support from NVentures (NVIDIA’s venture capital arm) and four major US health systems: Hartford HealthCare, Mercy, Sutter Health [...]

  • LISSUN acquires Being Cares for AI mental health

    Mental health platform LISSUN has acquired US-based Being Cares as it moves to integrate AI into family-focused mental healthcare services. The deal combines LISSUN’s therapist-led model with Being Cares’ AI-based mental health mapping system, aiming to deliver a tech-driven approach to care. Being Cares currently supports nearly one million users worldwide through its AI system, [...]

  • AI health firm Respiree raises US$11.6m Series A

    Health tech company Respiree has raised US$11.6m in Series A funding to expand its AI tools for managing disease progression across care settings. Founded in Singapore, the company said its augmented-AI platform is designed to support clinical decision-making by automating patient monitoring, care pathway management and the delivery of medical insights. One of its key [...]

  • Neuralink targets 20,000 brain chip patients by 2031

    Elon Musk’s Neuralink expects to implant brain chips in 20,000 people annually by 2031, generating at least US$1bn a year, according to documents reviewed by Bloomberg. The company plans to operate around five large clinics within six years and offer at least three versions of its device, according to a recent presentation shown to investors. [...]